One parameter that is not included in the evaluation, but which may be significant in countries where the cold chain capacity is more limited, is the capital cost of its expansion to accommodate the higher volume per PFIC associated with cPAD.
← all excerpts
Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and Peru.
1
—
—